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The role of social cognition in severe mental illness (SMI) has gained much
attention, especially over the last decade. The impact of deficits in socio-cognitive
functioning has been found to have detrimental effects on key areas of day-to-day
functioning in individuals with SMI, such as gaining and maintaining employment and
overall experienced quality of life. Treatment of individuals with SMI is challenging, as
the presentation of individual signs and symptoms is rather heterogeneous. There are
several treatment approaches addressing deficits ranging from broader social and
interpersonal functioning to neurocognitive and more intrapersonal functioning. As
research in the domain of social cognition continues to identify specific deficits and its
functional detriments, treatment options need to evolve to better target identified
functional deficits. Social Cognition and Interaction Training (SCIT) was recently
developed to address specific socio-cognitive deficits in an inpatient population of
individuals with schizophrenia-spectrum disorders. This study applied SCIT in an
outpatient SMI population as many deficits remain after individuals’ symptoms are less
severe and overall functioning is more stable than during the acute inpatient phase of
their rehabilitation. Specifically, this study has two objectives. First, to demonstrate that
deficits in social cognition persist after the acute phase of illness has abated. Second, to

demonstrate that these deficits can be ameliorated via targeted treatment such as SCIT.
Data was gathered in local outpatient treatment settings serving a heterogeneous SMI
population.
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Chapter 1 – Introduction
Social Cognition and Interaction Training (SCIT) for Individuals with Schizophrenia
Spectrum Disorders in Outpatient Treatment Settings
Social cognition has been defined as “the ability to construct representations of
the relations between oneself and others, and to use those representations flexibly to
guide social behaviors” (Adolphs, 2001). Research has established the adverse impact of
socio-cognitive dysfunction on clinical as well as functional outcome for individuals with
schizophrenia spectrum disorders (Brenner et al., 1994; Hogarty & Flesher, 1999).
Schizophrenia spectrum disorders have wide-ranging and debilitating effects on peoples’
lives. Social cognitive deficits have been an important domain of functioning with
deficits manifested in peoples’ ability to establish and maintain meaningful interpersonal
relationships to gaining and maintaining employment as well as the overall perceived
quality of life (Corin & Lauzon, 1994; Davidson, Stayner, & Haglund, 1998; Mueser,
Becker, & Wolfe, 2001; Mueser, Salyers, & Muser, 2001). Further, cognitive
impairments (such as deficits in memory, attention, and problem-solving) have been
found to negatively impact psychosocial functioning (including skills needed in areas of
vocational attainment and interpersonal functioning) as well as interfere with
rehabilitation goals overall (Green, 1998; Penn, Corrigan, & Racenstein, 1998); and
limited social competence has been linked to deficits in cognitive domains such as
attention and memory (Hogarty, 2000). Using structural equation modeling, Sergi and
colleagues suggested that social cognition and neurocognition are separate, yet closely
linked constructs (Sergi, Rassovsky, et al., 2007). As such, social cognition has been
called a mediator as it bridges more molecular domains (i.e. underlying neuro-cognitive
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abilities) with a more molar domain, the interactive social realm of functioning (Brekke,
Kay, Lee, & Green, 2005; Couture, Penn, & Roberts, 2006; Kee, Kern, & Green, 1998;
Sergi, Rassovsky, Nuechterlein, & Green, 2006). Green, Uhlhass, and Coleheart (2005)
suggested that functioning in the neurocognitive, socio-cognitive, as well as the broader
psychosocial domain should be combined for a better understanding not only of
schizophrenia but also for more informed treatment approaches aimed to improve
functional outcome in people with serious mental illness (SMI1). The vulnerability-stress
or diathesis-stress model (e.g. Zubin & Spring, 1975), and more recently the
neurodevelopmental model (Murray, O’Callaghan, Castle, & Lewis, 1992) are theoretical
formulations that incorporate multiple levels of organismic functioning, designed mostly
to clarify the etiology of SMI. The biosystemic model (e.g. Spaulding, Sullivan, &
Poland, 2003) is a similar formulation designed mostly to inform clinical assessment,
treatment and rehabilitation. Together these formulations create the broader theoretical
paradigm in which current research on social cognitive impairments and their treatment
proceeds.
The main hypotheses of this study examined the effectiveness of a newly
developed treatment approach looking to ameliorate social cognitive functioning in
individuals with schizophrenia spectrum disorders. The chosen treatment modality,
Social Cognitive and Interaction Training (SCIT), was developed by Penn et al. at the

1

SMI is an umbrella term used in mental health services policy and administration, and
more generally to connote people with chronic, disabling psychotic disorders including
schizophrenia and severe affective disorders. For scientific and scholarly purposes, SMI
is often, but not always, interchangeable with diagnostic terms such as “schizophrenia” or
paradiagnostic terms such as “schizophrenia-spectrum.” In this discussion, SMI refers to
the broader population, and other terms are used when reviewing specific studies that use
those terms as inclusion or independent variables.
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University of North Carolina and is currently undergoing rigorous testing in order to be
established as best practice in the field of SMI treatments. This study hypothesizes that
individuals receiving SCIT will show improvement in socio-cognitive domains after
receiving the treatment as compared to individuals who do not receive SCIT treatment.
As this study employed a waitlist-control format, all participants received SCIT by the
end of the study. It is hypothesized that by the end of the study, all participants will have
improved in socio-cognitive domains as addressed by SCIT.
Study participants were assigned to two groups: 1) SCIT then TAU (treatment as
usual), or 2) TAU then SCIT. Participants completed a comprehensive testing battery
three times over the course of the study: pre-treatment (baseline, testing time 1), after the
first set of SCIT groups ended (half of the participants are post-treatment, testing time 2),
and again after the second set of SCIT groups ended (all participants are post-treatment,
testing time 3). The testing battery included measures assessing current symptomatology,
neurocognitive functioning, and socio-cognitive functioning.
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Chapter 2 – Literature Review
Social Cognition in Severe Mental Illness
The term “social cognition” has gained increased attention, especially during the
past 15 years, and refers to “mental operations underlying social interactions, which
include the human ability and capacity to perceive the intentions and dispositions of
others” (Brothers, 1990). As established by the National Institute of Mental Health
(NIHM) initiative “Measurement and Treatment Research to Improve Cognition in
Schizophrenia (MATRICS),” essential components of social cognition include emotion
perception, social perception, social knowledge, theory of mind (ToM) and metacogntive
abilities, as well as attributional style (Green, Olivier, Crawley, Penn, & Silverstein,
2005; Green & Leitman, 2008). However, other studies refer to three (of the above
named five) components as primary domains: emotion perception, ToM, and attributional
style (Combs, et al., 2009; Penn, Sanna, & Roberts, 2008). Of these, emotion perception
and processing appears to be the most studied area of social cognition (Kee, et al., 2009).
These findings highlight the need for further study in order to identify the specific factor
structure and inter-relationships of these overlapping domains of social cognition.
Research has shown that individuals with schizophrenia-spectrum disorders have
difficulty with the skills and abilities mentioned above (Edwards, Jackson, & Pattison,
2002; Corrigan & Nelson, 1998; Corrigan & Toomey, 1995; Addington & Addington,
1998; Grant et al., 2001; Frith & Corcoran, 1996; Pickup & Frith, 2001). Further,
research has confirmed that social cognition mediates the relationship between
neurocognition and functional outcome (Brekke, et al., 2005; Gard, Fisher, Garrett,
Genevsky, & Vinogradov, 2009; Yager & Ehmann, 2006 ). As such, findings indicate
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that individuals with schizophrenia-spectrum disorders have difficulty with community
functioning and social adjustment and has identified cognitive deficits in the areas of
working memory, executive functioning and attention as underlying factors to these
socio-cognitive deficits (Green, Kern, Braff, & Mintz, 2000; Tso, Grove, & Taylor,
2009). In addition, studies utilizing techniques such as functional magnetic resonance
imaging (fMRI) and regional cerebral blood flow (rCBF) monitoring have found that
people with schizophrenia-spectrum disorders show a different pattern of brain response
compared to normal individuals, including deficits in neurochemistry (see West & Grace,
2001 for a detailed review). Deficits in neural substrates linking the prefrontal regions of
the brain with other areas (such as the amygdala and the limbic system) have been linked
to deficits in executive functioning, reasoning, self-awareness, and decision-making
(Tranel, Bechara, & Damasio, 2000). Such deficits can to some extent be addressed via
targeted repetitive learning (i.e. strengthening neuro-pathways in the brain), improving
cognitive control, and the teaching of mature thinking styles (Bell, Bryson, Fiszdon,
Greig, & Wexler, 2004; Spaulding et al., 1998; Wykes, Reeder, Corner, Williams, &
Everitt, 1999; Hogarty & Flesher, 1999).
Treatment of Social Cognitive Deficits
Psychopharmacological treatment may help with addressing some of the above
named deficits. Findings have been mixed in determining the effects of medication,
especially with regards to the remediation of negative symptoms and cognitive
impairment. Studies have found that, in contrast to positive symptoms, negative
symptoms and cognitive impairments tend to be more stable over time and less
responsive to treatment with antipsychotic medications (Kane & Marder, 1993; Greden &
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Tandon, 1991). However, more recent studies found some evidence that atypical
antipsychotic medications (e.g. olanzapine, risperidone, and clozapine) may have a
beneficial impact on negative symptoms and cognitive impairments (Meltzer & McGurk,
1999; Keffe, Silva, Perkins, & Lieberman, 1999; Wahlbeck, Cheine, Essali, & Adams,
1999). To date, studies specifically focused on the impact of pharmacological treatments
on socio-cognitive deficits are limited and inconclusive. While some studies found
treatment with atypical antipsychotic medications improved social perception as
compared to treatment with conventional antipsychotic medications (Littrell, Petty,
Hilligoss, Kirshner, & Johnson, 2004; Kee, Kern, Marshall, & Green, 1998), other studies
did not find any significant effect of pharmacological treatment on emotion perception
(Harvey, Patterson, Potter, Zhong, & Brecher, 2006; Herbener, Hill, Marvin, & Sweeney,
2005; Penn, Keefe, Davis, Meyer, Perkins, Losardo, et al., 2009; Sergie, Green, et al.,
2007). Overall, symptom reduction and stabilization often has a positive, if moderate,
effect on neurocognitive performance, with different medications affecting improvements
in different areas of cognitive functioning (e.g. verbal fluency, attention) as symptom
severity improves. Nonetheless, psychopharmacological intervention is just one part of a
comprehensive as well as individualized treatment approach.
Studies have found evidence for a link between cognitive functioning and
functional outcome in schizophrenia. The impact of change in cognitive functioning,
however, appears to be mediated by cognitive interventions. Research has found that
improvement in cognition is not sufficient to lead to functional change unless it is
achieved via targeted treatments (Wykes & Reeder, 2005). Studies have also focused on
identifying specific areas of socio-cognitive dysfunction in people with SMI.
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Furthermore, research has focused on how social cognitive difficulties impact people’s
lives and how this functional deficit can best be addressed in treatment. As such, research
has recognized aspects of social cognition as an important part to successful interpersonal
functioning in persons with schizophrenia (Couture, Penn, & Roberts, 2006; Penn,
Combs, & Mohmed, 2001). Difficulty with social functioning often adversely impacts a
person’s overall perceived quality of life (Grant, Addington, Addington, & Konnert,
2001, Penn, Corrigan, Bentall, Racenstein, & Newman, 1997). Intact social cognitive
abilities, including adequate social skills, thus impact the quality of social interactions,
which are an important factor in vocational functioning, establishing and maintaining
interpersonal friendships and relationships, and achieving a level of functioning sufficient
for independent community living (Dickinson, Bellack, & Gold, 2007). Impairment in
social functioning is also associated with higher relapse rates (Perlick, Stastny, Mattis, &
Teresi, 1992). These socio-cognitive deficits are best addressed in treatment via a social
learning approach, including modeling of behaviors and repetitively practicing target
behaviors in role-plays.
Existing socio-cognitive treatment modalities.
To date, several psychosocial treatment approaches have been developed and
successfully implemented in the treatment of people with SMI. Treatment format and
patient population are important characteristics to consider when choosing a specific
treatment approach for people with SMI. Current treatments for people with
schizophrenia-spectrum disorders utilize individual as well as group formats. Generally,
the more “social” treatment approaches tend to utilize a group format, whereas
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approaches that also target neurocognitive functioning utilize an individual or mixed,
individual and group, format.
Another factor to consider when choosing a specific treatment modality to address
socio-cognitive deficits is the symptom acuity of the patient. Some treatment modalities
are formulated targeting either an inpatient or an outpatient patient population; others can
be adjusted and administered with either group.
The following treatments are administered on an individual basis. Although they
do not specifically target socio-cognitive dysfunction per se, they have been found useful
in improving functioning in the social cognitive realm.
Cognitive remediation therapy (CRT) (Wykes & Reeder, 2005). CRT operates on
the premise that improvement in cognitive function will affect other functions, such as
socio-cognitive abilities. Specifically, CRT aims to improve executive functions (e.g.
planning skills), memory, attention, and the ability for cognitive shift (e.g. shift set).
Wykes and Reeder (2005) emphasize the importance of explicit teaching of reflective
processing coupled with practice of learned skills in order to improve metacognitive
abilities. The authors suggest the use of CRT in people with no co-existing substance
abuse problem or acquired traumatic brain injury as it would distract from the focus of
the program and render is much less successful. Similarly, the authors discourage use of
CRT in people who actively experience psychotic symptoms, as these as well would
distract from the treatment. In addition to the above named suitability factors, CRT also
assess participants’ motivation to participate in treatment and, most importantly,
motivation to change via the process. Sessions are conducted on an individual basis up to
three times per week. Even though CRT does not specifically focus on either inpatients or
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outpatients, studies have mostly been recruiting outpatients for treatment for reasons
mentioned above (e.g. symptom acuity etc). Overall, studies have found that the most
durable treatment effect was improvement in verbal memory performance. Wykes and
colleagues (1999) found that CRT participants improved in cognitive flexibility as well as
memory function. Further, Wykes and colleagues found some skills taught by CRT were
sustained over the six months after therapy was terminated. Specifically, improved
cognitive flexibility appeared to be related to changes in social functioning. However, no
direct effect of therapy on social functioning was found 6-months post-treatment (Wykes
et al., 2003). On a broader level of functioning, research has found both, CRT and IPT
(for a discussion on IPT see below) effective for reducing symptoms of SMI (Medalia,
Aluma, Tryon, & Meriam, 1998; Medalia, Dorn, & Watras-Gran, 2000; Spaulding et al.,
1999).
Cognitive-behavioral therapy (CBT) for psychotic disorders (Fowler, Garety, &
Kuipers, 1995). Even though CBT has originally been developed as a treatment approach
for depressive disorders (Beck, Rush, Shaw, & Emery, 1979), it has been modified to
target a variety of other disorders, including psychotic disorders. As such, CBT for
psychotic disorders is a structured treatment approach that has been successfully
implemented with inpatients as well as outpatients (Garety, Fowler, & Kuipers, 2000;
Gould, Mueser, Bolton, Mays, & Goff, 2001). A number of studies have used a CBT
approach to aid in the treatment of positive symptoms (Tarrier, Beckett, et al., 1993;
Tarrier, Sharpe, et al., 1993; Chadwick & Birchwood, 1994; Garety, Kuipers, Fowler,
Chamberlain, & Dunn, 1994). Findings from these studies indicate that CBT techniques,
such as challenging underlying beliefs, can help reduce delusions, general
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symptomatology, and alleviate depressive symptoms. Although CBT primarily targets
symptoms (i.e. psychosis), its central tenant is to reduce stress and symptom interference
with functional outcome; it has been shown that CBT improves patient’s ability to cope
with stressors and increase adherence to treatment and symptom management
(Turkington, Dudely, Warman, & Beck, 2006). In addition, Rector and colleagues found
that CBT, in combination with enriched treatment-as-usual (i.e. including case
management), lead to a reduction in negative symptoms at a six-month follow-up
(Rector, Seeman, & Segal, 2003). As such, CBT differs from other treatment approaches
reviewed here, as it does not directly aim to improve basic cognitive abilities related to
social functioning. Rather, CBT focuses on identifying and challenging dysfunctional
thought and belief systems, identifying cognitive biases, encouraging the patient to selfmonitor thoughts and beliefs, and helping the client relate cognitions to mood and
behavior. However, given the heterogeneity of schizophrenia-spectrum disorders,
treatment approaches need to be tailored individually to address the specific combination
of symptoms of the particular patient. The primary and underlying aim in CBT with an
SMI population is thus the identification of the patient’s vulnerabilities, stressors, and
response style (Fowler, Garety, Kuipers, 1998). Given the individual variability of
symptom presentation, CBT treatment ranges in duration of treatment and in frequency of
individual treatment sessions. Garety and colleagues (2000) describe offering on average
20 sessions of weekly or biweekly meetings with the therapist. However, the reported
range of sessions offered to individual clients is from 12 to 30 sessions conducted
anywhere between six months and one year. Fowler and colleagues (1995)
conceptualized CBT for psychotic disorders in six components that are intended to be

11
administered in any given order, depending on the patient’s needs. The components are
as follows:
(1)

Engagement and assessment (e.g. building rapport and developing trust,
utilizing interviewing strategies to obtain detailed and specific information
pertaining to patient’ s history, symptoms, etc.)

(2)

Coping strategy work (e.g. identifying and modifying existing coping
strategies; this may involve homework tasks such as keeping a record of
symptoms)

(3)

Developing an understanding of the experience of psychosis (e.g. evaluating
existing delusional beliefs and constructing a new way of making sense of
beliefs; this includes some psycho-education, which builds on patient’s
understanding of the disorder)

(4)

Working on delusions and hallucinations (e.g. through explorations of
misattributions and “jumping to conclusion” biases)

(5)

Addressing mood and negative self-evaluations (e.g. using standard cognitive
therapy approaches to address low self-esteem, etc.)

(6)

Managing the risk of relapse and social disability (e.g. reviewing learned
skills and strategies to prevent relapse).
Even though the authors state that these six components of CBT treatment can be

administered flexibly, there appears to be some encouragement to move through the
components (or stages) in a structured manner as many of the issues addressed during one
stage build on work done during previous CBT components. However, the authors
emphasize that, while moving through the treatment components, previous components

12
can be revisited as needed to aid understanding and preserve the therapist-patient
relationship. Overall, several studies have found CBT to be effective in individuals with
SMI, reporting that the treatment beneficially impacts positive symptoms, reduces
relapse, and aids overall recovery during the acute phase of the illness (Gould et al.,
2001; Pilling et al., 2002; Rector & Beck, 2001; Tarrier & Wykes, 2004).
Personal therapy for schizophrenia (Hogarty, et al., 1995). Personal Therapy
(PT) for Schizophrenia is similar in its treatment approach to CBT (described above). As
with CBT, PT aims to identify and modify stressors while focusing on relapse prevention
as well as the enhancement of personal and social adjustment for people with SMI.
However, unlike CBT, PT does not focus directly on positive symptoms or symptom
remission in general. To that end, PT’s focus is more on preventing relapse in patients
with chronic SMI who are stable, and less on patients with acute symptoms. Hogarty and
colleagues found that for patients with social support (i.e. living with family), PT reduced
relapse rates (but not for those patients living independently who have received PT);
similarly, patients who continued to participate in PT over an extended period of time
(i.e. over one year) showed more positive effects in social adjustment (Hogarty,
Kornblith, et al., 1997; Hogarty, Greenwald, et al., 1997). The treatment is delivered in
three phases:
1. The basic phase introduces the PT approach and is used to establish
rapport with the client. An individual treatment plan is formulated and
clients learn about their illness and treatment, including identifying their
individual signs and symptoms, stressors, and ways of coping.
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2. The intermediate phase focuses on maintaining and enhancing clinical
stability, continued psychoeducation (including adjustment to living with
the disorder), facilitating skill development to resume activities of daily
living. This phase also introduces relaxation techniques and social skills
training.
3. The advanced phase continues to build on previous phases of PT and also
addresses conflict resolution skills as well as social and vocational issues
important to recovery.
Overall, PT can be described as a modified approach to treatment of SMI clients,
combining psychotherapy, psychoeducation and case management strategies.
Functional cognitive-behavioral therapy (fCBT) (Cather, 2005). Functional
CBT focuses on increased functioning and well-being in people with schizophrenia. Penn
and colleagues introduce fCBT as “a brief individual treatment for schizophreniaspectrum disorders that targets residual symptoms that interfere with functional goal
attainment, including interpersonal goals” (Penn et al., 2004). Thus, fCBT differs from
the above-described CBT and PT treatments in that it does not focus as much on relapse
prevention. In addition, fCBT is intended to be a shorter treatment approach with 16
weekly sessions and 4 bi-weekly booster sessions. The sessions are broken down into
steps with different treatment foci as follows:
(1)

Session 1 introduces the fCBT treatment approach to the client and is used to
build rapport with the client.

14
(2)

Sessions 2 through 5 focus on identifying of functional treatment goals and
barriers to the achievement of goals, as well as on identifying and pursuing
pleasant activities in order to increase well-being and, overall, quality of life.

(3)

Sessions 6 through 16 focus on specific treatment modules addressing
specific deficits or symptoms the individual client is experiencing (e.g.
negative symptoms, delusions, difficulty with social relationships,
maladaptive coping strategies) via CBT approaches. However, unlike
traditional CBT, the authors emphasize an active approach to functional
improvement (e.g. scheduling activities and engaging in activities).

Although fCBT has been found to aid with the improvement of positive symptoms,
particularly auditory hallucinations, no significant improvements were noted in the realm
of social functioning (Cather et al., 2005). This is particularly interesting given the stated
focus of the fCBT treatment approach as one that emphasizes functionality over symptom
reduction. However, the authors noted that fCBT is a relatively recent treatment approach
that needs to be further evaluated via empirical studies.
Training of affect recognition (TAR) (Wölwer et al., 2005). TAR is a sociocognitive treatment approach aimed specifically at the remediation of deficits in facial
affect recognition in a SMI population. The training is conducted in small groups (two
participants and one therapist) and can be done with inpatients as well as outpatients.
However, the authors note that TAR is geared specifically toward less symptomatic and
more stable participants. TAR consists of a total of 12 sessions. Participants meet with
their therapist twice a week for 45-minute sessions. The training consists of emotion
perception exercises, ranging from the identification and discrimination of facial affect to
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the integration of facial expressions into a social-behavioral context and situational
context. This treatment approach has been found useful in producing significant
improvement in affect recognition abilities.
Cognitive-behavioral social skills training (CBSST) (McQuaid et al., 2000).
CBSST was developed with a middle-aged and older adult SMI population in mind. The
authors describe age-related patient characteristics such as increasing problems with
physical health, potential loss of support, as well as particular belief systems (i.e. “an old
dog can’t learn new tricks”) as factors influencing the development of CBSST (McQuaid
et al., 2000). Further, the authors acknowledge that both CBT and social skills training
(SST) have been found to include beneficial treatment strategies targeting the specific
treatment needs of an SMI population. The underling rationale is that CBT techniques
that have been found useful in the treatment of schizophrenia-spectrum disorder can be
enhanced for older adults when combined with a social skills training approach, stressing
repetition and practice of learned techniques and skills. In addition, the authors cite the
potential stigma toward psychotherapy in an older cohort, reasoning that going to “class”
may encourage more willingness to engage in treatment. The treatment approach consists
of self-contained therapy modules that can be arranged and administered in any given
order. CBSST is geared toward outpatients and usually administered in 12 weekly onehour sessions. The two overarching targets of CBSST are improvement in social
functioning as well as symptom reduction while keeping in mind the increased cognitive
difficulties faced by an older population. To that end, CBSST focuses on the impact of
beliefs or cognitions on mood and behavior as well as on the repetitive practice of
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pragmatic living skills. The manualized treatment approach consists of the following
three modules:
(1)

Focus on cognitive-behavior skills (including training in basic cognitionchallenging skills, using these skills to increase treatment adherence, gaining
increased coping skills and applying them to prevent relapse, and reducing
conviction regarding psychotic symptoms).

(2)

Focus on symptom self-management (including improving skills in areas of
problem-solving, identifying symptoms of relapse, and managing warning
signs).

(3)

Focus on symptom management and coping with persistent symptoms
(including medication adherence strategies utilizing mnemonic aids and
environmental structuring, and cognitive and behavioral strategies to identify
and cope with ongoing symptoms).

Some of the above named approaches are taken from the UCLA Social and Independent
Living Skills Series (Psychiatric Rehabilitation Consultants, 1991), especially from the
Symptoms Management Module. Other approaches and techniques were taken from the
traditional CBT approach and used in modified ways to address the specific needs of
older individuals with SMI. A pilot study conducted by the authors showed that CBSST
is beneficial for participants, especially with regards to treatment engagement and
adherence.
As mentioned above, treatment interventions specifically targeting social
cognitive dysfunction are mostly administered in a group format. Usually, group sizes
average about six patients and one or more instructors. The following treatment
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modalities have been successfully used with people with schizophrenia-spectrum
disorders.
Integrated psychological therapy (IPT) (Brenner et al., 1992). IPT is a wellvalidated, manualized treatment intervention developed to improve neurocognitive and
socio-cognitive abilities as well as social skills in people with schizoprenia (Roder,
Mueller, Mueser, & Brenner, 2006). The underlying premise that basic neurocognitive
deficits have cascading effects on higher-level social and interpersonal functioning is
addressed via different treatment modules that aim to improve necessary cognitive skills
in order to effectively teach higher-level skills. With this sequential effect in mind, IPT
modules are intended to be taught in order, starting with the more molecular
neurocognitive functions and working up to a more molar level of social behavior. This
group-based intervention is made up of five treatment modules that target these different
levels of functioning. The domains are: (1) cognitive differentiation, (2) social
perception, (3) verbal communication, (4) social skills, and (5) interpersonal problem
solving. As such, IPT spans abilities and functions related to neurocognition and social
cognition as well as social competence. Specifically, the domains focus on improving the
following skills and abilities:
(1) The cognitive differentiation module addresses neurocognitive abilities such as
attention, verbal memory, cognitive flexibility, and concept formation. Unlike
other treatment programs, this IPT subprogram aims to improve functioning in
these areas via group exercises focusing on strategy learning.
(2) The social perception module addresses social cognitive abilities such as social
and emotional perception and emotional expression. This subprogram aims to
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improve participants’ apprehension and interpretation of social situations via
group exercises utilizing slides depicting various social situations.
(3) The verbal communication module aims to bridge underlying functional abilities
with overt behavioral skills. As such, it focuses on neurocognitive abilities that
directly impact interpersonal communication skills such as verbal fluency and
other skills related to executive functioning. The module revolves around the
basic communication skills of listening, understanding, and responding.
(4) The social skills module focuses on fostering social competence in participants
and uses in vivo role-plays as a focal strategy.
(5) The interpersonal problem-solving module adds group-based problem solving
exercises and thus utilizes skills learned during prior subprograms.
As mentioned above, the IPT subprograms are designed to be administered
sequentially, but, depending on symptom acuity of participants and targeted skills and
abilities, only relevant subprograms may be administered. Studies up to date have found
persistent positive global therapy effects independent from the specific number of
subprograms administered (Roder et al., 2006).
IPT has been implemented in inpatient as well as outpatient settings. However, as
Roder and colleagues address in their recent meta-analysis of studies that utilized the IPT
treatment approach, studies done with outpatients were limited in number, but
nonetheless showed positive effects regarding the amelioration of targeted dysfunctions
(Roder et al., 2006).
Cognitive Enhancement Therapy (CET) (Hogarty & Greenwald, 2006).
Cognitive Enhancement Therapy combines individual computer-based training of
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cognitive abilities with group-based social cognition training. Overall, the CET approach
to treatment is based on the “mastery principle” with participants repetitively working on
skills until the training goal is achieved. Given the approaches and goals inherent in CET,
participants benefit most from this treatment approach once their symptoms are in
remission and stable. Thus, CET targets a stable, non-substance abusing outpatient
population and is recommended for use with participants with an IQ of 80 or higher
(Hogarty, Greenwald, & Eack, 2006). CET uses specific components first used in the IPT
approach and is heavily based on Ben-Yishay’s general stimulation holistic program
originally developed for use in people with traumatic brain injury (Ben-Yishay et al.,
1985). Further, CET tailors treatment to individual needs based on cognitive style (i.e.
cognitive impairment is understood via domain associated cognitive deficits that can be
impoverished, disorganized, or rigid). CET seeks to identify participants’ individual
cognitive style and tailor training approaches with these specific symptom presentations
in mind. For example, the training for individuals presenting with an impoverished
cognitive style, treatment focuses heavily on learning skills related to elaboration and a
more “gistful” construction of cognitive schemas. Similarly, for participants with a
disorganized cognitive style, treatment will focus on improvement of attention and
planning skills. Lastly, CET training with individuals identified as having a rigid
cognitive style, treatment focuses on generating alternatives and becoming more flexible
in behavior as well as in cognitions (Hogarty & Flesher, 1999a). Hogarty and Flesher
(1999b) indicate that at the core of CET lies meta-cognition. The authors stress the
importance of “gistful” appraisals and automatic processing. As such, the focus is on
metacognitive abilites and training includes tasks targeting improvement of processing
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speed, attention, memory, as well as problem solving skills. CET consists of
approximately 56 social-cognitive group sessions lasting 90 minutes. In addition,
neurocognitive deficits are approached via approximately 75 one-hour sessions using
computer exercises. Specifically, the first part of CET is devoted to mastery of tasks
pertaining to the above-mentioned domains of neurocognitive functioning. While the
computer-based training occurs in individual session, the second part of CET focuses on
fostering social cognitive function and social adjustment and occurs in a group setting.
Throughout CET treatment, each participant also receives individual supportive therapy
and medication management. Overall, studies have shown that CET results in improved
neurocogntive functioning and psychosocial adjustment (Eack, Hogarty, Greenwald,
Hogarty, & Keshavan, 2007; Hogarty et al., 2006; Hogarty et al., 2004).
Social Cognition and Interaction Training (SCIT) (Penn et al., 2007). SCIT is a
manual-based treatment approach that has been recently developed to address social
cognitive dysfunctions in people with schizophrenia-spectrum disorders, especially
individuals with paranoid symptoms. Specifically, SCIT addresses deficits in emotion
perception, social perception and social cognitive biases, attributional style, cognitive
flexibility, social relationships, and theory of mind related skills. SCIT, initially
developed for use with an inpatient population, is structured as a group-based treatment
approach consisting of 20 training hour-long sessions with sessions conducted up to three
times per week. This treatment approach consists of three phases of training:
(1) Understanding emotions: This module incorporates a “personalized”
understanding of social cognition (i.e. exploring the concept via personal
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experiences of participants) and defining basic emotions and relating them to
facial expressions.
(2) Exploring social cognitive biases: This module includes exploration of common
biases held, especially by individuals with paranoid symptoms, and focuses on the
“jumping to conclusions” phenomena as well as offers alternative strategies to
avoid the pitfalls ambiguous situations can provide.
(3) Integrating materials from previous sessions: This final module aims to aid
participants to apply learned materials and skills into their everyday lives.
A pilot study conducted by Penn and colleagues (2005) found that inpatients
trained with SCIT showed moderate improvement in attributing hostile and aggressive
intent in others, emotion perception, and showed significant improvement in ToM
measures (Penn, Roberts, Munt, Silverstein, Jones, & Sheitman, 2005). Combs and
colleagues have conducted another study of the efficacy of SCIT in a forensic inpatient
population and found that individuals improved in all targeted social cognitive domains
(Combs, Adams, Penn, Roberts, Tiegreen, & Stem, 2007).
Social cognition enhancement training (SCET) (Choi & Kwon, 2006). SCET is
a group-based treatment approach designed for stable, non-substance abusing outpatients
with SMI. The central tenet of SCET is improvement in social cognitive functioning. The
focus is on a subset of social cognition, specifically ToM-related skills such as social
context appraisal and perspective-taking skills. The SCET treatment approach consists of
a total of 36 90-minute sessions twice per week. The sessions are divided into three 12session levels: elementary, middle, and advanced. SCET utilizes four-column cartoons to
train individuals on social perception, emotion recognition, and social cue perception
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skills. Tasks include arranging the cartoon in the right order based on contextual
information. Participants are encouraged to discuss strategies as well as problem-solve
social situations similar to the ones depicted in the cartoon. So far, results from SCET
treatment trials have shown improved performance on a laboratory task assessing for
abilities related to social context appraisal (Picture Arrangement, WISC-R). SCET is a
rather recent addition to the social cognition treatment approaches.
The Future of Social-Cognitive Treatments for SMI Populations
Research in the field of social cognition has highlighted the importance of social
cognitive abilities (e.g. social and emotional perception) in mediating cognitive
functioning and broader social functioning in the SMI population. As such, functional
outcome (i.e. social behavior in the treatment milieu and community functioning) has
been tied not only to symptom reduction and stabilization (e.g. Medalia et al., 1998), but
also to improved cognition and social cognition (e.g. Penades et al., 2003). For example,
in a recent review of social cognition and functional outcome, Couture and colleagues
emphasized evidence for a relationship between social perception and various domains of
functional outcome (Couture et al., 2006). However, research has devoted less attention
to the functional significance of other social cognitive domains (i.e. ToM and
attributional style). Improving functional outcomes in individuals with SMI has been an
essential tenant in the development for social cognitive treatment approaches, especially
with regard to their potential to become acknowledged as evidence-based practice. To
that extent, the above reviewed interventions can be viewed as interventions targeting
specific domains of social cognition (e.g. SCET) and interventions that target a broader
range of social cognitive abilities (e.g. IPT and SCIT).
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As described above, there are several psychosocial interventions to date that
explicitly target social cognitive dysfunction in individuals with SMI (e.g. Brenner,
Hodel, Roder, & Corrigan, 1992; Hogarty & Greenwald, 2006; Penn, Roberts, Combs, &
Sterne, 2007). The clinical outcome research is rapidly moving toward recognition of
such interventions as evidence based practice. However, different interventions address
different dimensions and domains of social cognition. Research on both intervention
development and clinical outcome is increasingly focusing on which specific dimensions
and domains are actually involved in treatment and recovery processes, which are most
accessible to treatment, and which are most important with regard to personal and social
functioning in the real world. Nevertheless, the scientific priority for outcome data on
broad, multi-component treatment also remains high. Both types of research are needed
now and in the near future.
The range and diversity of existing treatment modalities, however, make it
difficult to determine the logical next steps in research. Different modalities focus on
different social cognitive abilities and impairments. There are striking differences in the
modalities’ time courses (or “dosage,” to use a pharmacological term). Although the
overall research results suggest clinical effectiveness, the outcome expectations and
measures are too diverse to allow any more specific conclusions. Ultimately, one should
expect that specific modalities or packages of modalities will be identified as optimally
effective for specific clinical presentations or constellations of impairments, but this will
come only after years of clinical trials. Meanwhile, it seems that a reasonable research
strategy is to study one modality that strikes a balance between focus and
comprehensiveness, that is, a modality that addresses a moderate range of specific social
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cognitive impairments whose ecological validity has a reasonable degree of face validity.
Controlled or partially controlled trials of such a modality will gradually expand the
database of social cognitive treatment toward future meta-analyses that will consolidate
confidence that this approach has substantial promise. The values of such trials will be
enhanced when they are done in a context that allows additional study of the factors that
enhance or inhibit response to treatment. Similarly, the values of these trials will be
enhanced when outcome can be measured in terms of specific cognitive changes, as well
as functional recovery.
Present Study
The purpose of this dissertation project is to further scientific understanding of
treatment for social cognitive impairment in SMI. The project includes an empirical
study of such treatment in the form of a controlled outcome trial. The choice of treatment
is based on a comprehensive review and analysis of previous findings on social cognitive
impairment, its role in personal and social functioning, and its amenability to treatment.
Specifically, this study aims to demonstrate that deficits in social cognition can be
ameliorated via a targeted treatment approach such as SCIT. As such, this study is a
clinical trial of a social cognitive treatment modality in a context that allows for
systematic evaluation of different outcome domains and possible moderators of the
treatment effect. The modality chosen for this project is the Social Cognition and
Interaction Training (SCIT). Developed by Penn and colleagues, SCIT addresses a range
of social cognitive domains within an average time frame (a total of 20 training sessions).
It can be used independently, i.e. is not reliant on additional interventions such as social
skills training. SCIT has been developed and tested primarily in inpatient settings, with
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only one preliminary study in community settings published so far (Roberts, Penn, and
Labate, 2010). We designed the present study to evaluate a targeted treatment for social
cognition deficits (SCIT) in a severely mentally ill population in real-world settings. As
such, the heterogeneity of schizophrenia spectrum disorders in community participants as
well as constraints imposed by the real-world setting calls for a hybrid design rather than
a conventional controlled trial. In this project, a series of SCIT groups were conducted in
outpatient settings that serve people with SMI. Clinical and neurocognitive assessment
data were included to explore the possible role of clinical and neurocognitive factors as
moderators of the treatment effect. The offered social cognitive treatment approach aims
to be inclusive of important socio-cognitive domains identified by research thus far.
Specific social cognitive impairments addressed by SCIT include emotion and social
perception (including social cues, facial affect recognition), social cognitive biases and
attributional style (e.g. “jumping to conclusions”), cognitive flexibility, and ToM skills. It
is hypothesized that individuals participating in SCIT treatment groups will improve in
the above named domains over the course of SCIT treatment as compared to individuals
receiving the standard outpatient care regimen. This hypothesized treatment effect was
measured via the social cognition outcome measures described below. Specifically, it is
hypothesized that each group will show improved performance on the social cognition
measures after receiving SCIT treatment. Thus, Group 1 (SCIT then TAU) is expected to
show improvement on assessment 2, while Group 2 (TAU then SCIT) is expected to
show improvement on assessment 3 (see Figure 2.1).
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Figure 2.1 Central hypothesis of the present study.
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Chapter 3 - Method
Participants
Forty participants with a primary diagnosis of an Axis I psychiatric disorder in the
schizophrenia spectrum participated in this study. Individuals in outpatient treatment
settings were enrolled in the study if the met the following inclusion criteria: between 19
and 64-years of age, current DSM-IV diagnosis of schizophrenia or schizoaffective
disorder, stable antipsychotic medication regimen, no concurrent substance abuse or
dependence, no mental retardation, and no organic brain injury or pathology.
Overall, 42 individuals agreed to participate in the study. Two individuals
withdrew consent before the study commenced and where excluded from the final study
sample. The remaining 40 participants were selected into two groups: 1) SCIT – TAU,
receiving SCIT therapy first and then TAU; and 2) TAU – SCIT, receiving TAU first and
then participated in SCIT therapy. Randomness in participant selection and group
assignment was constrained by individual schedules as well as schedules and availability
of space at treatment sites. Although this prevented truly random sampling and
assignment, the circumstances allowing participation and driving group assignment were
themselves sufficiently random to allow the expectation of a reasonably unbiased
process.
Assessments were conducted at three time-points: at baseline (pre-intervention),
after the first set of SCIT groups were completed (when participants switched from SCIT
to TAU or TAU to SCIT), and after the second set of SCIT groups was completed (postintervention). All 40 participants completed baseline assessments. Of these 40, 36 (10%
attrition) completed the interventions (18 in the SCIT – TAU group; 18 in the TAU –
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SCIT group). Of these, 31 participants agreed to complete the second assessment phase;
and 26 completed the third and last assessment phase. Thus, all participants took part in
baseline testing, with an attrition rate of 22.5% and 35% for the following assessment
phases respectively.
Treatment Settings and Population Sample
Participants for this treatment approach were recruited from community-based
care settings in Lincoln, NE. The settings served as hosts and performance sites for the
assessment and therapy activities of the study. They were chosen as representative for
serving people with especially severe and disabling mental illness but functioning outside
an institutional setting. The settings also generally operate within a biopsychosocial
understanding of mental illness guided by principles of rehabilitation and recovery. This
creates a climate in which introductions of new skill training and therapy modalities are
normal and routine occurrences. A close working relationship between the UNL
psychology department, the Community Mental Health Center of Lancaster County, and
OUR Homes, Inc. made it possible to conduct the study with minimal disruption to
ongoing services. The assessment activities and therapy sessions were integrated into the
normal operations of the host programs in an effort to make the study activities a natural
part of the setting. In collaboration with the study PI, the SCIT therapists composed
progress notes for each participant, according to agency conventions for group therapy.
These were entered into the respective participants’ clinical records.
The recruiting pool created by the performance sites is expected to be highly
heterogeneous with respect to any demographic and clinical measures commonly used in
psychiatric research, except for diagnosis and occupational functioning. Diagnoses are
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overwhelmingly in the schizophrenia spectrum. Almost by definition, people in
psychiatric day programs have significant difficulties in occupational functioning. The
interaction of diagnostic and functional factors can be presumed to create a recruiting
pool reasonably representative of people in the lower middle third of the distribution of
global functioning, e.g. as measured by Axis V of the DSM. This is compatible with
expectations of who stands to benefit from SCIT.
Midtown Center
The Midtown Center is an adult day rehabilitation program for individuals with
SMI. Approximately 50 individuals attend the program daily (Monday-Friday) and are
encouraged to take an active role in their rehabilitation through participation in the dayto-day program operation (e.g. lunch preparation, answering phones, publishing daily and
monthly newsletters, etc.). Midtown Center is administered by the Community Mental
Health Center of Lancaster County.
Southville Center
The Southville Center is a day rehabilitation program for adults with SMI. The
program encourages “healthy living” and, to that extent, offers individuals exercise
classes and well-balanced food-choices. Further, Southville Center offers tutors and
classes, helping individuals work on achieving personal goals (e.g. obtaining a GED). A
maximum of 120 individuals attend Southville Center on a daily (Monday-Friday) basis.
The Southville Center is administered by OUR HOMES assisted living facilities.
Treatment Conditions
This research project examines the efficacy of a social cognitive treatment
intervention, Social Cognition and Interaction Training (SCIT) developed by Penn and
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colleagues at the University of North Carolina-Chapel Hill (UNC). The SMI research lab
at UNL has had close ties with the UNC research group lead by David Penn over several
years. Of the existing social cognitively oriented treatment approaches, SCIT was chosen
as it was recently developed and appears to target an essential range of social cognitive
domains and promises to ameliorate functional impairment in an SMI population. As
such, this research will compare a manual-based treatment approach (SCIT) to treatmentas-usual (TAU) as offered in targeted treatment settings. TAU in identified treatment
settings usually consists of case management (including medication management), plus
various occupational, rehabilitative and supportive services, especially for the population
segment sampled in this study.
Measures
Demographic information. Demographic information will be collected form
participants regarding age, gender, race, psychiatric diagnosis, highest education level
completed, current living situation, and currently received treatments and/or services and
treatment and/or service providers. In addition, all participants will be assessed using the
following clinical, neurocogntive, and social cogntive measures.
Clinical measures and neurocognitive measures.
Brief Psychiatric Rating Scale (BPRS; Ventura et al., 1993). This semistructured interview provides an efficient and quick way to assess symptom change in
persons with severe mental illness. It consists of 24-items of which 14 are interviewbased and 10 are based on observed behavior and/or speech during the interview. The
administration manual for the BPRS provides interview questions, symptom definitions
and specific anchor points for rating symptoms. Ratings are based on severity as well as
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frequency of experienced symptoms and range from 1 (not present) to 7 (extremely
severe). Thus, the total score on the BPRS can range from 24 to 168, with higher scores
indicating more severe and frequent psychopathology. The BPRS is one of the most
widely used measures in psychiatric outcome studies as well as clinical
psychopharmacology research. Studies supported the BPRS as a well-validated and
reliable assessment measure and found it to consist of four core factors, which underlie
the structure of the BRPS. The factors are anxiety/depression (including BPRS items
somatic concern, anxiety, depression, suicidality, and guilt), thinking disorder (including
BPRS items of grandiosity, hallucinations, unusual thought content, bizarre behavior, and
conceptual disorganization), withdrawal (including BPRS items disorientation, blunted
affect, emotional withdrawal, elevated mood, self-neglect, and motor retardation), and
activity (including BPRS items tension, excitement, motor hyperactivity, distractability,
and mannerisms and posturing) (Burger, Calsyn, Morse, Klinkenberg, & Trusty, 1997;
Thomas, Donnell, & Young, 2004; Velligan et al., 2005).
Neuropsychological Assessment Battery – Screening Module (NAB-Scr; Stern
& White, 2003). The NAB-Screener is a recently developed neuropsychological
assessment to evaluate cognitive functioning in adults aged 18 to 97. The modular
assessment battery consists of subtests that target critical domains of cognitive
functioning, including attention, language, memory, spatial, and executive functions. The
evaluation also provides an overall or total screening index indicating the level of overall
cognitive functioning. Given the recent development of the NAB, studies evaluating its
psychometric properties are very limited at this time. However, two reviews published in
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the Mental Measurements Yearbook indicate that the NAB is based on extensive
normative and validation data (Makatura, 2005; Van Gorp & Hassenstab, 2005).
Trail Making Test - Trails A and B (Reitan & Davidson, 1974). The original
Trail Making Test was developed in 1944 as part of the Army Individual Test Battery and
now is a standard component of the Halstead-Reitan Neuropsychological Test Battery
(Reitan & Wolfson, 1995). The Trail Making Test is a paper-and-pencil measure of
visual processing and visuo-motor tracking (Lezak, 1995) and is used to measure
capacity for organization and sequencing. Trails A requires the participant to connect 25
numbered dots that are randomly spread across a sheet of paper in sequence during a
timed administration (i.e. number 1 through number 25). Trails B is more demanding, as
it requires the participant to connect a series of 25 randomly distributed dots on a sheet of
paper containing numbers and letter in an alternating sequence (1-A-2-B-3-C etc.) during
a timed administration. Participants are stopped and alerted to errors in sequencing,
requiring them to go back to the last correct stop and redirect their sequencing to correct
their performance. Scores for both Trails A and B are based on the time an individual
needs to correctly complete each task. Efficient performance on the Trail Making Test,
especially Trails B, depends in part of facets of working memory and sufficient cognitive
flexibility.
Controlled verbal fluency task (FAS; Borkowski, Benton, & Spreen, 1967). A
test of verbal fluency; participants are given a total of three letters, one letter at a time (F,
A, and S) and have 60 seconds to responds with as many words as possible that start with
the given letter. Proper nouns were scored as incorrect; total number of correct words
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generated within the allotted 60 seconds for each of the three trials is added up and used
as the final score.
Letter-Number Sequencing (LNS; WAIS-III; Wechsler, 1997). The LNS subtest
of the WAIS tests participants’ attention and working memory by reading a sequence of
intermixed letters and numbers (e.g. Q-1-B-3-J-2) to them at a rate of 1 per second, which
they have to repeat back to the examiner after manipulating the order and place the
numbers in ascending numerical order and then the letters in alphabetical order. The
letter-number sequences become increasingly longer and range from 2 stimuli (e.g. A-3)
to a maximum of 8 stimuli. A total of three trials are presented at each length with the test
being discontinued after the participant fails three consecutive trials of the same length.
Each correctly manipulated sequence receives a score of 1, for a maximum score of 21.
Social cognition measures.
Hinting Task (Corcoran, Mercer, & Frith, 1995). The Hinting Task is a theory
of mind (ToM) measure administered as part of a social cognition assessment battery.
ToM is of particular interest in understanding the relationship between cognition and
social interactions and refers to the ability to infer the intentions and beliefs of others. It
has been found that persons with schizophrenia have difficulty utilizing inductive
reasoning to infer the attitudes and intentions of others (Frith, 1992). Additionally, ToM
deficits appear to be unique to persons diagnosed with schizophrenia (Janssen,
Krabbendam, Jolles, & van Os, 2003). In fact, Corcoran (2003) found that persons with
schizophrenia rely on a different strategy to understand the meaning behind pragmatic
language compared to a non-clinical population. The Hinting Task consists of ten short
vignettes involving two people and asks the participant to infer the intention behind
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veiled speech acts. Each vignette ends with one of the characters saying something to the
other. After each vignette is presented, participants are asked a question regarding the
characters intention (e.g. “What does George really mean when he says this?” or “What
does Paul want Jane to do?”). Each vignette is read out to participants and available for
participants to read through as many times as necessary. If participants cannot make an
inference or arrive at an inappropriate solution, more detail is added to the interaction
giving a more obvious hint regarding the underlying meaning to the participants. Scores
range from 0 to 2 per vignette (for a total score range of 0 to 20) with lower scores
indicative of a more concrete understanding of the vignette and higher score indicative of
a better understanding of underlying intentions of the characters in the depicted
interaction. Although there is limited psychometric data available, the Hinting Task is
sensitive to deficits in schizophrenia, correlates with other ToM measures and has good
face validity in studies with seriously mentally ill participants (Corcoran et al., 1995;
Corcoran & Frith, 2003; Yager & Ehmann, 2006).
Social Perception Scale (Garcia, Fuentes, Ruiz, Gallach, & Roder, 2003).
Garcia and colleagues (2003) developed the Social Perception Scale in order to assess the
following criteria: stimuli identification, interpretation of images, and title assignment.
This measure consists of four photographs that are presented to participants. Two of the
pictures were chosen because of their cognitive complexity and the other two because of
their emotional content. Participants are presented with one photograph at a time and
asked to carefully look at the picture. Participants are told that the same set of questions
will be asked for all four pictures and are asked to limit their answers to what appears in
the picture and to not make any assumptions. Questions asked are: 1) Could you tell me
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what details/elements/things you can actually see in this photo? 2) Could you tell me
what is happening in this photo, keeping in what you told me before? 3) What title would
you give to this photo? In a few words, mention the key elements of the picture.
Participants are evaluated on the basis of whether they were able to address the three key
concepts of the photograph: situational context, actor/s and action or interaction amongst
them. One point is given for each aspect mentioned, points are added up to comprise a
total score indicating the number of correctly identified details. It should be noted that the
Social Perception Scale does not measure social functioning or social skills, rather it aims
to measure cognitive abilities necessary in social perception. Given the relative recent
development of this measure, studies to determine psychometric features have yet to be
undertaken. Although its use so far has been limited, studies using the Social Perception
Scale found effective in measuring cognitive abilities necessary for intact social
perception (Combs, Adams, et al., 2007; Fuentes, Garcia, Ruiz, Soler, & Roder, 2007;
Ruiz, Garcia, Fuentes, Garcia-Merita, 2005). Even though the Social Perception Scale has
very limited psychometic data available, it was chosen as an outcome measure because
social perception is a social cognitive construct specifically addressed by the SCIT
treatment module.
Ambiguous Intentions Hostility Questionnaire (AIHQ; Combs, Penn, Wicher,
& Waldheter, 2007). The AIHQ is a new measure specifically targeting social cognitive
bias (hostility) in schizophrenia-spectrum disorders. It consists of 15 short vignettes
reflecting negative outcomes that vary in intentionality (i.e. intentional, accidental, and
ambiguous intentions). In a preliminary study to evaluate the psychometric properties of
the AIHQ, the authors reported supportive findings regarding the validity and reliability
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of the measure. However, this study was conducted with a non-clinical sample and did
not address test-retest reliability. Other preliminary findings indicate that the AIHQ is
predictive of violence and aggression in an inpatient sample of people with schizophrenia
(Waldheter, Jones, Johnson, & Penn, 2005). Most importantly, the AIHQ has been found
to be a sensitive outcome measure in a SCIT treatment trial in inpatients with
schizophrenia (Penn et al., 2005).
Need for Closure Scale (NFCS; Webster & Kruglanski, 1994). The NFCS is
used to assess the extent to which a person, faced with a decision or judgment, desires
any answer (as compared with confusion and ambiguity). The authors derive the need for
cognitive closure from two general tendencies: urgency and permanence. The urgency
tendency refers to the inclination to attain closure immediately and to seize any early
information that can potentially lead to closure. The permanence tendency refers to the
inclination to maintain closure for as long as possible and to stick with information
leading to the achieved closure. The NFCS is a 16-item Likert-type scale designed to
assess attitudes, beliefs, and experiences related to the tolerance of ambiguity with higher
scores indicating a greater need for closure.
Emotional Context Perception Task (ECPT; Choi, Liu, Kleinlein, Wynne,
Spaulding, 2006). The ECPT is a computerized task assessing the perception and
recognition of emotional cues. It consists of 40 cartoon portrayals depicting a cartoon
character expressing one of nine emotions (fear, disgust, contempt, shame, anger,
surprise, sadness, happiness, and neutral). This character is depicted either in a group of
people who also express an emotion or alone (blank background). The 40 stimuli include
8 portrayals without contextual emotions (blank background) and 32 portrayals with
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contextual emotions (“main character” in a group of people). Participants are asked to
identify the emotion by answering a multiple-choice question and to rate the intensity of
the identified emotion on a 7-point Likert scale.
Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, Wetton, &
Copestacke, 1990). The SFS is a 79-item scale designed to assess functioning in
individuals with schizophrenia-spectrum disorders. It targets the level of ability in seven
areas: 1) social engagement (e.g. “how much time do you spend alone?”), 2)
interpersonal communication (e.g. “how many friends do you have?”), 3) activities of
daily living (e.g. “how often do you prepare and cook a meal?”), 4) recreation (e.g. “how
often do you play a sport?”), 5) social activities (e.g. “how often do you visit friends?”),
6) competence at daily living (e.g. “how able are you to handle your own money?”), and
7) occupation/employment (e.g. “are you in regular employment?”). Although the
questionnaire can be filled out by the participant, typically the examiner will ask the
questions and fill out the form. This scale has been shown to be a reliable, valid, and
sensitive measure of social functioning (Birchwood et al., 1990).
Attributional Style Questionnaire (ASQ; Peterson, Semmel, von Baeyer,
Abramson, Metalsky, & Seligman, 1982). The ASQ is a questionnaire consisting of 48
Likert style items designed to measure the causal attributions offered by patients
regarding good or bad events in their lives. The attributional dimensions assessed with
this instrument include internal-external, stable-unstable, and global-specific. Each item
is measured on these dimensions via separate 7-point Likert scales. This measure has
been found to be a valid and realible assessment of people’s attributional style (Seligman,
1991; Sweeney, Anderson, & Bailey, 1986).
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Multnomah Community Ability Scale (MCAS; Barker et al., 1994). The MCAS
is a 17-item Likert-type scale specifically designed to assess level of functioning in
individuals with SMI. The scale is completed by the individual’s community support
worker or case manager and includes four subscales (interference with functioning,
adjustment to living, social competence, and behavioral problems) and an overall (total)
score of functioning. Good test-retest reliability and internal consistency haven been
reported (Barker et al., 1994).
Emotional Context Perception Task (ECPT; Choi, Liu, Kleinlein, Wynne,
Spaulding, 2006). The ECPT is a computerized task assessing the perception and
recognition of emotional cues. It consists of 40 cartoon portrayals depicting a cartoon
character expressing one of nine emotions (fear, disgust, contempt, shame, anger,
surprise, sadness, happiness, and neutral). This character is depicted either in a group of
people who also express an emotion or alone (blank background). The 40 stimuli include
8 portrayals without contextual emotions (blank background) and 32 portrayals with
contextual emotions (“main character” in a group of people). Participants are asked to
identify the emotion by answering a multiple-choice question and rate the intensity of the
identified emotion on a 7-point Likert scale.
Face Emotion Identification Task (FEIT; Kerr and Neale, 1993). The FEIT
utilizes black and white still photographs of facial emotions developed by Ekman and
Friesen (1976) and Izard (1971). It was administered in the computerized version
consisting of 19 black and white still photographs presented for approximately 15
seconds each, with an interval of 10 seconds between photographs. During the interval,
the participants were asked to pick one of six basic emotions (i.e. happy, sad, angry,
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surprised, afraid, and ashamed) that best describes the face in the previous photograph,
Each emotion corresponded to a number (1-6) on the screen and participants pressed the
corresponding key on the keyboard to finalize their answer and move on the next
photograph. The total number of correct answers was used as the final score for this task.
Voice Emotion Identification Task (VEIT; Kerr and Neale, 1993). The VEIT
was administered in the computerized version consisting of 21 audio recordings of
verbally presented statements with neutral content (e.g. “He tossed the bread to the
pigons”, “Fish can jump out of the water”). Participants were asked to rate the voice tone
that best describes each statement and chose their answer from a list of six basic emotions
(i.e. happy, sad, angry, surprised, afraid, and ashamed). As with the FEIT, each emotion
was listed with a corresponding number (1-6) that participants used to record their answer
via the corresponding keyboard key. The total number of correctly identified items was
used for the final score of this task.
Benton Facial Recognition Test (BTFR; Benton, Hamsher, Varney, & Spreen,
1983). The BFRT consists of a series of sheets containing photographs of physically
similar faces (i.e. not showing hair or glasses). Participants are presented with a sheet
containing a single “target” face and are asked to match the target to a set of six face
photographs for a total of 22 trials. The first six trials consist of participants selecting one
matching face photograph; the remaining trials ask participants to identify three correct
matches from a total of six face photographs presented in different angles (i.e. the face
changed in orientation or lighting conditions compared to the target photograph).
Bell Lysaker Emotion Recognition Task (BLERT; Bell, Bryson, & Lysaker,
1997). The BLERT is an affect perception task and was administered in its computerized
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version consisting of 21 short video clips. In each clip, an actor reads one of three neutral
scripts, while displaying one of seven basic emotions (i.e. happy, sad, angry, afraid,
surprised, ashamed, and neutral). After each clip, participants are asked to pick the
emotion that best describes the actor in the video from a list of seven emotion. As with
the FEIT and VEIT, each answer choice on the computer screen corresponds with a
number on the keyboard that is used by participants to make their answer choice. The
total number of correctly identified emotions is used as the final score on this task.
Design and Procedure
Power analysis. Using the standard power level of .80, the expected n for this
study is 20 subjects per group (overall N=40). Effect sizes from previous studies by Penn
and colleagues (2005; 2007) and Combs, Adams, and colleagues (2007) on the AIHQ
ranged from r = .50 to r = .82 and specific sample sizes ranged from N=6 to N=28. A
reasonable attrition rate, considering all the subjects are in long-term rehabilitation
programs before this study even begins, is 10%. The remaining 36-subject sample is well
within the sample sizes used by Penn and colleagues as well as Combs and colleagues in
initial demonstrations of effectiveness of this modality (Penn, et al., 2005; Penn, et al.,
2007; Combs, Adams, et al., 2007).
Participant recruitment. Staff in treatment settings as well as the primary
investigator checked available medical records to determine if participants meet the
inclusion criteria. Once the participants were identified, they were approached by staff
(incl. the primary investigator) and given information about the study and the opportunity
to enroll. After informed consent was obtained and HIPPA rules explained, the
participants were selected into either one of two treatment groups: 1) first receiving SCIT
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and then TAU, or 2) first receiving TAU and then SCIT. Participants were selected rather
than randomly assigned into treatment groups in order to maximize comparability
between SCIT and TAU groups in terms of participant characteristics (e.g. age, gender).
All participants, regardless of treatment group, completed both phases of the study and as
such participate in SCIT treatment groups as well as the control (TAU) group, differing
only in the sequence in which the phases were completed. This study enrolled a total 20
participants in each treatment condition for a combined total of 40 participants. Previous
pilot studies conducted by Penn and colleagues and an inpatient trial conducted by
Combs and colleagues obtained significant study results with smaller samples (N=17 and
N=18) (Penn, et al., 2007; Combs, Adams, et al., 2007).
Experimental design and treatment conditions. This study is based on a
hybrid, quasi-exprimental, rather than a conventional experimental design due to
restrictions imposed by the real-world setting of this study, including the heterogeneity of
schizophrenia spectrum disorders in community participants and working with individual
schedules as well as accommodating time and space restrictions at each treatment site.
The present study consist of two treatment phases. Thus, Phase I (with post-treatment
assessment) would in itself be a complete controlled trial under conventional research
conditions. We hope that, given the inherent limitations of this study, Phase II will
compensate for the small sample and other limitations that would otherwise compromise
a purely Phase I design. The treatment conditions included in this empirical analysis
include a social cognitive treatment modality (SCIT) and treatment-as-usual (TAU).
Hence, the design of the study is a 2 (Treatment: SCIT vs. TAU) X 3 (Time of
assessment: pre-treatment vs. between treatment vs. post-treatment) mixed group
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factorial design. Thirty-six participants (out of the 40 enrolled participants) completed
both treatment conditions (phases), SCIT and TAU, differing only in the order in which
SCIT and TAU are received. Group 1 received SCIT, followed by TAU; Group 2
received TAU, followed by SCIT. SCIT treatment groups and control (TAU) groups each
consisted of six to eight participants. The primary investigator as well as a co-leader led
all groups. A total of 20 bi-weekly one-hour treatment sessions were conducted in
community-based psychiatric care settings. The SCIT was provided according to the
treatment manual developed by Penn and colleagues (Roberts, Penn, and Combs, 2007).
Three treatment groups were conducted in each of two study phases, yielding 18 subjects
in the first group (SCIT first) and 18 subjects in the second group (TAU first):

Group 1
(N=18)

Phase 1

Phase 2

SCIT n=6
SCIT n=6
SCIT n=6

TAU

TAU

SCIT n=6
SCIT n=6
SCIT n=6

Group 2
(N=18)

Figure 3.1 Study design: Treatment groups.
Participants in the control group (TAU) continued to receive their individual standard
care regimen typically consisting of medication management, case management and a
range of occupational, rehabilitational and supportive services. No alternative, added
treatment was offered. Participants in both groups participated in pre-, between- and posttreatment assessments:
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Group 1
(N=18)

Group 2
(N=18)

Assessment
Battery
Completed

Phase 1

Phase 2

SCIT n=6
SCIT n=6
SCIT n=6

TAU

TAU

(n=40)

Assessment
Battery
Completed
(n=31)

SCIT n=6
SCIT n=6
SCIT n=6

Assessment
Battery
Completed
(n=26)

Figure 3.2 Study design: Treatment groups and testing phases.
Participants received $5 for their participation after completion of each assessment phase
for a total of $15 at the end of the study.
Treatment fidelity. Two group leaders who are involved in this project as
graduate level research assistants were assigned per treatment group. Dennis Combs,
Ph.D., who has worked with SCIT and participated during various stages of the
development of SCIT, has provided an all-day training workshop for the application of
SCIT on June 3, 2008. All group leaders involved in this project participated in all parts
of this workshop and were trained by Dennis Combs, Ph.D. on the application of SCIT
and running treatment groups using the SCIT manual. In addition, mock treatment
groups were used to train group leaders in the application of SCIT and the adherence to
the SCIT treatment manual. All research assistants were either graduate students in the
Clinical Psychology Training Program and members of the Serious Mental Illness
research laboratory at UNL (E. Cook, B.A., C. Davidson, B.A., M. Tarasenko, B.A., A.
Collins, M.A., L.F. Reddy, B.A., A Wynne, B.A., K.H. Choi, M.A.) or have been
involved as research assistants with the SMI research group at the Lincoln Regional
Center. Graduate students were involved in the assessment as well as function as SCIT
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group leaders in this study; other research assistants were only involved in the assessment
phases of this study. All research assistants involved in the data collection part of this
study had prior experience with administration of the measures used in this study.
Data analysis.
Data preparation. Confidentiality of participants was protected and all identifying
information removed from data materials. All participants were assigned a subject ID
number (in lieu of name, date of birth, chart numbers, etc.) to represent them in the
database. Once all the data was coded this way, it was entered into SPSS (SPSS, Inc.,
2006) by the primary investigator. Univariate analyses were used to investigate any data
entry errors, values beyond the defined range of data coding options, missing values,
skewness, and kurtosis. Both univariate and bivariate analyses were used to examine
outliers. Data entry errors, out-of-range values, and missing values were rechecked in the
original participant files. These values were then corrected or left blank in the instance of
missing information. Outliers were either be trimmed or transformed, depending on the
individual case and the outlier’s effects.
Statistical analysis. Preliminary data analysis uses analysis of variance (ANOVA)
and χ2 tests to compare demographic background and clinical presentation pre-treatment
to ascertain that the two groups are initially equivalent and to obtain descriptive sample
information. Gender was used as a covariate in all subsequent analyses of social cognitive
outcome variables (see Figure 4 for group composition by gender). The central
hypothesis (SCIT treatment improves performance on social cognitive outcome
measures) was explored via 21 ANCOVAs conducted on the social cognitive outcome
measures (dependent variables) to compare Group 1 (SCIT then TAU) to Group 2 (TAU
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then SCIT) (independent variables) in order to establish a treatment effect of SCIT on
social cognitive functioning. Specifically, ANCOVAs are used to determine differential
change over time between the two groups. Mean differences are used to qualitatively
interpret quantitative interaction terms.

Figure 3.3. Gender distribution: Number of women and men per group.
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Chapter 4 - Results
Demographic and Clinical Characteristics
Table 4.1 summarizes the demographic and baseline clinical characteristics of the
treatment groups (Group 1 = SCIT then TAU; Group 2 = TAU then SCIT). ANOVA and
χ2 tests revealed no significant differences between groups with regards to participants’
education (years of completed education), age, diagnosis, treatment site and current
symptomatology at baseline. However, the groups differed significantly in gender
makeup (χ2 = 4.8, p = .028). The potential impact of this difference on study hypotheses
was probed. Within the full sample, bivariate correlations between gender and baseline
social cognitive performance was significant for the BTFR (r = -.336, p = .034) and
AIHQ Aggression (r = -.363, p = .021), indicating that men scored significantly higher on
these measures (BTFR between group t(38) = 2.20, p = .03; AIHQ Aggression between
group t(38) – 2.40, p = .02). Higher scores on the BTFR indicate more correctly
identified facial expressions; a higher score on the AIHQ Aggression scale indicates a
more aggressive response to ambiguous situations. Gender was used as a covariate in
order to address these baseline differences in subsequent analyses of the social cognitive
data.
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Table 4.1
Demographic and Clinical Characteristics
SCIT-TAU
(n = 20)

TAU-SCIT
(n = 20)

Total
(n = 40)

M (SD) or
M (%)

M (SD) or
M (%)

M (SD) or
M (%)

37.10 (10.60)

44.25 (14.04)

40.68 (12.80)

Gender (%) *
Female
Male

8 (20%)
12 (30%)

2 (5%)
18 (45%)

10 (25%)
30 (75%)

Years of Education

11.85 (2.13)

12.68 (2.32)

12.26 (2.24)

Ethnicity (%)
Caucasian
Hispanic

19 (47.5%)
1 (2.5%)

20 (50%)
0 (0%)

39 (97.5%)
1 (2.5%)

5 (12.5%)

5 (12.5%)

10 (25%)

5 (12.5%)

8 (20%)

13 (32.5%)

10 (25%)

7 (17.5%)

17 (42.5%)

Diagnosis – Axis II (%)
None
BPD
Paranoid PD
Avoidant PD
Other

17 (42.5%)
1 (2.5%)
1 (2.5%)
0 (0%)
1 (2.5%)

18 (45%)
0 (0%)
0 (0%)
1 (2.5%)
1 (2.5%)

35 (87.5%)
1 (2.5%)
1 (2.5%)
1 (2.5%)
2 (5.0%)

Treatment Site
Midtown Center
Southville Center

12 (30%)
8 (20%)

8 (20%)
12 (30%)

20 (50%)
20 (50%)

Age
(range: 21 – 61 years)

Diagnosis – Axis I (%)
Schizophrenia,
Paranoid Type
Schizophrenia,
Undiff Type
Schizoaffective
Disorder

* Gender: χ2 = 4.8, p = .028
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Table 4.2 summarizes symptomatology and neurocognitive characteristics for all
study participants at baseline (time 1 testing). ANCOVAs indicated that the two groups
did not differ on measures of symptoms and neurocognition at baseline; neither did
performance on these measures differ between treatment sites.

Table 4.2
Baseline (Testing Time 1) Symtomatology and Neurocognitive Characteristics

SCIT-TAU
(n = 20)

TAU-SCIT
(n = 20)

Total
(n = 40)

M (SD)

M (SD)

M (SD)

BPRS Total
Factors:
Thought Disorder
Anergia
Affect
Disorganization

38.20 (9.89)

41.45 (7.67)

39.83 (8.89)

3.77 (2.05)
2.54 (1.05)
5.84 (2.50)
3.11 (1.37)

4.21 (2.27)
3.05 (1.49)
6.60 (2.51)
3.26 (1.12)

3.99 (2.15)
2.80 (1.30)
6.22 (2.50)
3.19 (1.24)

Trails A
Trails B

44.65 (29.82)
144.45 (127.41)

48.40 (36.29)
134.75 (89.78)

46.53 (32.95)
139.60 (108.90)

FAS

27.80 (11.12)

30.20 (14.13)

29.00 (12.61)

Letter-Number
Sequencing

8.10 (3.45)

7.65 (3.98)

7.88 (3.68)

NAB Screening
Total

437.85 (76.51)

442.55 (78.27)

440.20 (76.43)
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Treatment Findings
The effects of SCIT on social cognition were analyzed in a series of 2 (group: Group 1 SCIT then TAU versus Group 2
TAU then SCIT) X 3 (time: pretest versus posttest 1 versus posttest2) mixed model analyses of covariance (ANCOVAs)
(Table 4.3 shows the means for each condition of the design). Gender was used as a covariate in all analyses of outcome
measures. Of the 21 conducted ANCOVAs, two yielded a significant time x group interaction effect (FEIT and MCAS
Health), three yielded trend-level significant time x group interaction effects (BTFR, SPS Identified Stimuli, and SPS Title);

Table 3
Performance on Social Cognition and Social Functioning Measures (adjusted with gender as covariate)
Testing Time 1
SCIT-TAU

TAU-SCIT

M (SD)

M (SD)

Testing Time 2

Testing Time 3

SCIT-TAU

TAU-SCIT

SCIT-TAU

M (SD)

M (SD)

M (SD)

TAU-SCIT
M (SD)

FEIT Total*

11.17 (1.64)

11.36 (4.22)

11.92 (3.15)

10.36 (3.34)

10.92 (1.78)

12.57 (3.84)

VEIT Total

10.58 (2.68)

9.00 (3.26)

11.17 (3.21)

8.79 (3.04)

10.08 (3.45)

9.14 (3.28)

BLERT Total

11.75 (3.57)

11.29 (5.29)

12.42 (3.50)

11.50 (4.62)

12.67 (5.07)

11.93 (4.86)

BTFR Total **

39.33 (4.64)

41.71 (6.33)

40.00 (5.03)

40.93 (6.37)

41.08 (6.37)

41.21 (6.58)

ECPT Total***

8.42 (2.43)

6.93 (3.15)

8.17 (2.12)

5.43 (2.28)

8.08 (3.99)

5.29 (2.81)
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SPS
Identified
Stimuli+
Interpretations
Title ++

38.75 (12.07)

32.93 (10.28)

28.83 (7.99)

33.57 (12.77)

35.17 (10.50)

37.36 (12.06)

7.75 (2.01)
3.67 (1.92)

8.08 (2.09)
3.93 (1.82)

8.17 (1.47)
4.17 (3.07)

8.86 (1.46)
3.21 (2.69)

8.33 (.98)
3.92 (1.98)

7.86 (2.14)
4.79 (1.53)

Hinting Task Total

15.25 (4.77)

15.71 (3.63)

14.75 (4.50)

15.79 (3.68)

16.83 (3.69)

17.36 (2.59)

NFCS Total

50.50 (9.35)

54.93 (11.25)

47.08 (8.33)

52.07 (12.06)

50.33 (7.64)

52.00 (8.16)

ASQ Total

2.67 (2.90)

1.71 (2.76)

2.58 (2.91)

1.50 (1.91)

2.42 (1.93)

1.57 (2.10)

AIHQ
Blame
Hostility
Aggression ~

3.20 (1.00)
2.18 (.78)
1.95 (.34)

3.04 (.62)
2.10 (.73)
2.07 (.39)

2.81 (.77)
2.22 (.73)
2.02 (.32)

3.13 (.60)
2.19 (.64)
2.00 (.25)

2.94 (.76)
1.83 (.52)
1.98 (.29)

3.07 (.69)
1.97 (.58)
1.84 (.26)

65.08 (11.85)
20.00 (3.81)
10.50 (3.23)
17.25 (4.18)
17.33 (2.19)

65.07 (10.56)
19.07 (3.29)
10.00 (2.39)
18.50 (4.27)
17.57 (1.50)

114.33 (18.83)
20.17 (3.16)
10.67 (2.57)
17.50 (3.78)
17.67 (1.83)

118.33(16.48)
21.14 (2.68)
10.36 (2.21)
18.29 (3.63)
18.57 (1.22)

118.92 (16.25)
20.58 (3.03)
10.92 (2.23)
19.17 (3.33)
17.58 (2.31)

121.86 (21.03)
21.00 (3.19)
11.07 (2.92)
19.93 (3.67)
17.16 (2.98)

11.67 (1.72)

11.14 (2.91)

11.83 (1.59)

11.29 (2.84)

11.83 (1.75)

11.07 (2.50)

7.83 (1.47)

7.21 (1.85)

7.83 (.94)

7.14 (1.61)

7.83 (1.53)

7.07 (1.86)

MCAS
Total±
Health±±
Adaptation
Social Skills±±±
Behavior
SFS
Social
Engagement
Interpersonal
Communication

n (SCIT) = 12; n (TAU) = 14
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*FEIT: F(2 22) = 6.018, p = .008 (time x group interaction)
**BTFR: F(1 23) = 2.909, p = .102 (time x group interaction)
***ECPT: F(1 23) = 8.366, p = .008 (group main effect)
+SPS Identified Stimuli: F(2 22) = 4.247, p = .028 (time main effect); F(2 22) = 2.891, p
= .077 (time x group interaction)
++SPS Title: F(2 22) = 2.682, p = .091 (time x group interaction)
±MCAS Total: F(2 22) = 65.402, p < .01 (time main effect)
±±MCAS Health: F(2 22) = 4.737, p = .019 (time x group interaction)
±±±MCAS Social Skills: F(2 22) = 2.411, p = .113 (time main effect)
~AIHQ Aggression: F(2 22) = 2.61, p = .096 (time main effect)
Of the 21 ANCOVAs, two yielded a significant time x group interaction effect:
FEIT (F(2 22) = 6.02, p = .008) (see Figure 5) and the MCAS (Health, F(2 22) = 4.74, p
= .019) (see Figure 6); neither the main effects for time nor treatment group were
statistically significant for these measures. Within and between group t-tests for the FEIT
scores did not identify the source of the significant time x group interaction effect, but
visual inspection of the mean changes within and between groups suggests that Group 1
improved immediately after receiving SCIT treatment (Time 1-2 within group t(12)= .92, p = .38), but did not sustain that improvement over time as performance declined at
the final assessment (Time 2-3 within group t(11) = 1.51, p = .16); for Group 2,
performance declined after receiving TAU (Time 1-2 within group t(17) = 1.14, p = .27 ),
but improved on the final assessment after receiving SCIT treatment (Time 2-3 within
group t(13) = -3.56, p = .003).
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Figure 4.1. Group means for FEIT (adjusted with gender as covariate).

The significant time x group interaction for the MCAS Health (see Figure 4.2)
indicates that while Group 1 showed neither statistically significant decline nor
improvement on this measure over time (Time 1-2 within group t(12) = -.46, p = .66;
Time 2-3 within group t(, Group 2 significantly improved performance after receiving
TAU (Time 1-2 within group t(17) = -3.22, p = .005) and sustained this improvement
after completing SCIT treatment (Time 2 -3 within group t(13) = .22, p = .83). Thus, the
below depicted MCAS Health graph shows the significant interaction was due to a
change not attributable to SCIT.
The time x group interactions for two of the Social Perception Scale measures
(see Figures 4.3 and 4.4 below) indicate trend level statistical significance. The
interaction effect for SPS Title (F(2 22) = 2.68, p = .091) indicates that Group 1
improved immediately after receiving SCIT treatment (Time 1-2 within group t(12) = -

53
.66, p = .52), but did not sustain that improvement (Time 2-3 within group t(11) = .464, p
= .65), Group 2’s performance declined after receiving TAU (Time 1-2 within group
t(17) = .33, p = .75) but improved significantly after receiving SCIT treatment (Time 2-3
t(1) = -2.75, p = .02) (see Figure 4.3).

Figure 4.2. Group means for MCAS – Health (adjusted with gender as covariate).

Figure 4.3. Group means for SPS title (adjusted with gender as covariate).
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The trend-level interaction effect for SPS Identified Stimuli (F(2 22) = 2.89, p =
.077) and indicates that Group 1 performed significantly poorer after receiving SCIT
treatment (Time 1-2 within group t(12) = 3.61, p = .004) but improved significantly by
the third assessment (Time 2-3 within group t(11) = -2.38, p = .04), whereas Group 2
showed steady improvement over time (Time 1-2 within group t(17) = -.46, p = .65; Time
2-3 within group t(13) = -1.11, p = .29; Time 1-3 within group t(13) = -1.42, p = .18). In
addition, the main effect for time was significant for SPS Identified Stimuli (F(2 22) =
4.25, p = .028) (see Figure 4.4).

Figure 4.4. Group means for SPS Identified Stimuli (adjusted with gender as covariate).
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The main effect for group was statistically significant for ECPT (F(1 23) = 8.366,
p = .008), with better overall performance of Group 1 versus Group 2 (see Figure 4.5).

Figure 4.5. Group means for ECPT (adjusted with gender as covariate).

Other significant or trend-level significant main effects for time were found for
the following measures: MCAS (Total Score: F(2 22) = 65.40, p < .01), with both groups
improving significantly after Time 1 (see Figure 4.6).

Figure 4.6. Group means for MCAS Total score (adjusted with gender as covariate).
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The main effect of time reached a trend level of statistical significance for the
following measures: AHIQ (Aggression: F(2 22) = 2.61, p = .096), with Group 1’s
performance initially declining but improving during the last assessment, while Group 2
improved performance over time (see Figure 4.7);

Figure 4.7. Group means for AIHQ Aggression (adjusted with gender as covariate).

Hinting Task (F(2 22) = 3.02, p = .096), with both groups showing improved
performance by the third assessment (see Figure 4.8).

57

Figure 4.8. Group means for Hinting Task (adjusted with gender as covariate).

To further explore the data, these results were further probed with 2x2
ANCOVAs as well as univariate ANCOVAs. As expected, no mean difference was found
for Time 1 testing on performance of social cognitive and social functioning outcome
measures between the two groups (Group 1 = SCIT then TAU; Group 2 = TAU then
SCIT). For Time 2 testing, Group 1 is expected to have improved performance after
receiving SCIT treatment. Results indicate that Group 1 (SCIT first) performed better on
the following outcome measures as compared to Group 2 (TAU first): BTFR (F(2 28) =
3.45, p = .046) (see Figure 4.9), SFS Interpersonal Communication (F(2 28) = 3.88, p =
.033) (see Figure 4.10), and ASQ (F(2 28) = 2.91, p = .071) (see Figure 4.11). No other
significant mean differences between groups were found. Finally, Group 2 was expected
to improve performance on outcome measures at Time 3 testing (after also receiving
SCIT treatment), while Group 1 was expected to sustain level of performance. A
significant time x group interaction indicating decrease in performance on the FEIT (F(1
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23) = 12.040, p = .002) for Group 1 while performance for Group 2 improved. A time x
group interaction for the SPS (Title; F(1 23) = 4.793, p = .039) indicates that Group 2
demonstrated significant improvement while performance for Group 1 stayed that same.
Further, a trend-level significant main effect for time for the MCAS (Adaptation; F(1 23)
= 2.965, p = .099) indicates the groups’ performance improved between the second and
third assessment (see Figure 4.12).

Figure 4.9. Group means for BTFR (adjusted with gender as covariate).
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Figure 4.10 .Group means for SFS Interpersonal Communication (adjusted with gender
as
covariate).

Figure 4.11. Group means for ASQ (adjusted with gender as covariate).

Figure 4.12. Group means for MCAS Adaptation (adjusted with gender as covariate).
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Time 3 testing signified post-treatment testing for both groups. As expected, no
mean difference was found in performance on all social cognition measures between the
groups during Time 3 testing.
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Chapter 5 - Discussion
General Discussion
This study contributes to the small but growing number of studies testing the
impact of SCIT and comparable treatment modalities on social cognitive functioning.
Although a range of treatments exist targeting deficits in cognitive, neurocognitive,
and/or social cognitive deficits in individuals with severe mental illness, the
heterogeneity of schizophrenia-spectrum disorders makes it difficult to treat individual
areas of deficit in a comprehensive yet viable way. SCIT is a promising new approach to
ameliorate deficits in social cognitive functioning by balancing necessary treatment
components (i.e. identified deficit domains) with a viable way of administration during a
typical time frame (20 sessions) via personally relevant and real-world exercises. Thus,
by targeting “hot cognition,” cognition with personally relevant content, SCIT promises
to be ecologically valid, increasing the translatability of learned materials between the
class room and other areas of participants’ lives.
Findings of the Present Study
Of the 40 participants in the final study sample, 65% completed all testing and
90% completed the SCIT intervention. The rate of attrition (35%) for assessments is high,
and exceeds the forecast 10% attrition rate. Several factors contributed to this particular
rate of attrition, including some individuals being discharged to other programs and/or
moving out of the catchment area, others asked to drop-out as the time commitment was
too much and/or they lost interest in continued participation.
Emotion measures. Three of the five emotion measures used in this study
showed evidence of a SCIT treatment effect in the domain of emotion perception. This is
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in line with previous studies where SCIT was administered (Roberts, et al., 2009; Combs,
et al. 2009). Other studies targeting social cognitive deficits also found improvement of
facial affect perception (Wolwer, et al, 2005; Horan, et al. 2009). However, the current
study did not find sustained improvement in emotion perception. There was a decrease in
scores for participants in Group 1 between the second assessment (immediately after
receiving SCIT treatment) and the third assessment (after receiving TAU, without SCIT
for 3 months). Results showed this pattern of improvement for the FEIT, BTFR, and the
SPS. Previous studies have found a similar pattern in results; Combs and colleagues
(2009) found that participants improved on the FEIT immediately after receiving SCIT
treatment, but did not sustain these improvements at a 6-month follow-up assessment.
However, the authors did note that, while performance declined significantly, it did not
decline to baseline and was found to be on par with the non-psychiatrically ill control
group. The present study generated no evidence for a SCIT treatment effect on the
BLERT or the VEIT.
ToM measures. The results yield only weak support for a SCIT treatment effect
on Theory of Mind as measured by the hinting task. Both groups improved somewhat on
this task by the last (third) assessment, with Group 2 improving performance after
receiving SCIT treatment. However, Group 1 showed a delayed improvement effect as
performance initially decreased after receiving SCIT treatment, but subsequently
increased after receiving TAU. The lack of a statistically significant difference may be
due to the general high scores achieved on the Hinting Task, which may indicate a ceiling
effect. This could indicate that this task may be useful for more acutely symptomatic
inpatients, or more severely disabled institutional patients, but may not measure more
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nuanced ToM deficits in a stable outpatient population. Other studies testing the
effectiveness of SCIT on social cognitive deficits, however, did find improved
performance on ToM measures after participants received the SCIT intervention
(Roberts, et al., 2009; Combs, et al., 2007; Penn, et al., 2005). It should be considered,
however, that these studies were conducted in inpatient settings where participants may
have exhibited greater ToM deficits as measured by the Hinting Task at baseline,
allowing measurement of possible improvement due to SCIT treatment.
Attributional style measures. Results of this study indicate that both groups
improved in performance on the AIHQ (Aggression subscale) by the third assessment;
only Group 1 showed improvement on the AHIQ (Blame subscale) immediately after
receiving SCIT and sustained this improvement at the third assessment. However, a
trend level decline in performance on the ASQ was found for both groups on the second
and third assessment. The groups did not show a significant mean difference in
performance, indicating no difference in attributional style after receiving SCIT
treatment. No significant effect was found for either group on the NFCS.
Social functioning measures. The current study found participants increased
their performance on the SFS (interpersonal communication subscale) after receiving
SCIT treatment; this finding is consistent with previous findings by Combs and
colleagues (2009). Participants achieved higher ratings on the MCAS (total score) after
the first assessment; both groups sustained this improvement at the third assessment.
Further, both groups showed improvement on the Adaptation subscale of the MCAS
between the second and the third assessment. Finally, only Group 2 improved their
ratings on the MCAS (Health subscale) over time.
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Limitations of the Present Study and Future Directions
We designed this study to evaluate a targeted treatment for social cognition
deficits in a severely mentally ill population in real-world settings. As such, the
heterogeneity of schizophrenia spectrum disorders in community participants resulted in
limitations for this study that would not be present in a sample of matched research
participants. Thus, the quasi-experimental nature of this study may prevent a more
confident assignment of treatment effects specifically to SCIT, which may be achieved
via a more rigorously controlled study. The current study serves as a preliminary analysis
for the implementation of SCIT in outpatient treatment settings.
As indicated in previous discussions, results may be impacted from lower than
expected statistical power; a bigger study sample may allow for more statistically
significant findings with regards to social cognitive outcome measures. It should be
considered that the predicted attrition rate was based on previous studies conducted in
inpatient settings as compared to the outpatient treatment settings in this study where
ambient expectorations of treatment participation may differ. In addition, the higher than
expected rate of attrition was limited to assessment completion (35%), while the expected
rate of attrition (10%) was found for treatment completion. Although this smaller size
during the assessment phase may impact statistically significant findings, it does not
necessarily reflect a less strong treatment effect of SCIT. In light of this discrepancy of
attrition rate between treatment completion and assessment completion, current findings
indicate that SCIT should be considered a viable and feasible treatment for social
cognitive deficits in an outpatient population. Participants appeared to enjoy the treatment
and the 10% attrition was due to either a change of schedule or a move/discharge of the
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participant from the treatment site. On the other hand, the higher rate of assessment
attrition was heavily influenced by the time consuming process of testing (approximately
4 hours at each testing phase) and the small remuneration ($5 per completed assessment
phase). As the demanding testing schedule is not typically not part of the treatment
process to the extent is was here, the treatment effects documented by this study may be
more solid for a purely clinical application of the treatment. Overall, a bigger sample size
and advanced statistical modeling may allow for more nuanced results. As such, the
present study functions as a precursor allowing and encouraging continued study of
targeted treatment approaches for social cognitive deficits in an SMI population.
Even though the effect sizes for results for social cognitive outcomes measures
were in the small to medium range, findings from the current study do indicate a
treatment effect for SCIT. Improvement in some domains (e.g. emotion perception, social
functioning) replicated findings from previous SCIT studies (Roberts, et al., 2009;
Combs, et al. 2009) and contribute to the study of treatment effects on specific social
cognitive domains. However, while finding some indication of a treatment effect, current
as well as previous outcomes did not necessarily indicate persisting treatment effects
(Combs, et al., 2009). This lack of persistent outcome effects may not entirely reflect a
weak or non-existent treatment effect as it could also be due to longitudinal fluctuations
in test performance that reflects actual fluctuations in functioning independent of
treatment effects. Overall, the longitudinal stability of functioning in these domains is not
well understood and could be interfering with our ability to measures treatment effects.
More research is needed to further validate and delineate separate social cognitive
domains. The heterogeneity of schizophrenia-spectrum disorders makes a clear separation
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of domains rather difficult. However, a steadily growing number of studies in this area
show promise in establishing a more precise theoretical groundwork.
Further, outcomes from the current study indicate that it is in the realm of
feasibility to administer SCIT in outpatient treatment settings and achieve some clinically
significant change. If participant enthusiasm for the treatment and the overall level of
engagement in treatment sessions is any indication for the promise of this targeted social
cognitive treatment, at least with regards to the feasibility and acceptability, then this
study established just that. Although these indicators have not been explicitly measured,
informal feedback from study participants was most uniformly very positive. Participants
stated that they very much enjoyed the group sessions and many reported that that they
felt more confident in interpersonal situations and felt that attending SCIT groups helped
them better connect with others in the treatment setting. In addition, staff observed that
clients who participated in SCIT treatment groups appeared to enjoy group sessions and
observed frequent discussions relating to participants’ experiences in group. Positive
feedback regarding SCIT treatment replicates findings from previous SCIT studies (Penn,
Roberts, Combs, and Sterne, 2007; Roberts, Penn, and Labate, 2009) and serves as an
indicator of overall client engagement in treatment. This is especially important with
regards to the overall higher level of difficulty of keeping SMI clients engaged in
outpatient treatment (Kreyenbuhl, Nossel, and Dixon, 2009.).
This study contributes to the growing body of literature and existing studies
needed for the establishing the feasibility of this new social cognitive treatment
intervention. Our findings are encouraging as they reflect a replication of prior studies,
including the informally assessed level of client engagement and enthusiasm for this

67
treatment modality. The presence of some treatment effects in this study makes a strong
case for the effectiveness of this treatment, especially in light of the low statistical power
and the potential of underestimating treatment effects that are present but remain
statistically undetected. These improvements, especially in functional domains (e.g. as
measured by the MCAS), are very compelling and make a strong case for going ahead
with large scale treatment trials. In that sense, additional studies will be necessary not
only to replicate findings, but also to determine generalizability of SCIT as well as the
degree to which beneficial treatment effects are sustained by SCIT participants after
treatment has concluded.
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